Multi-Client Studies and Market Research
Unique individual reports based on primary research conducted by industry consultants.
IHS Global Insight's multi-client studies (MCS) are designed to provide unique and in-depth insight to key questions and challenges facing the healthcare industry. The MCS employ a qualitative approach, including over 50 interviews conducted by local consultants with healthcare stakeholders from each country. MCS are fully customizable, allowing clients to validate and modify interview guidelines to accommodate specific business needs. The studies are enhanced by our healthcare and pharmaceutical team of experts and resources, providing a solid basis for analysis and forecasts.
Each Healthcare and Pharmaceutical MCS offers:
- An electronic report detailing the methodology of our research and the results of our in-depth studies and interviews
- Detailed country profiles for each survey delivered in Microsoft Word® (approximately 20-30 pages)
Each report applies a tailor-made methodology that is adapted to the deliverables of each project, using marketing tools such as B2B interviews, consumer and B2B surveys (phone, face to face, or Internet-based), panels, and "mystery shopping." Clients enter at an early stage of scoping the topic, and are able to tailor its format—as well as the precise questions of the interview guide—to suit their particular needs. We put the client at the center of each report to ensure optimum client delight.
The following is a list of available Healthcare and Pharmaceutical MCS:
- Orphan and Ultra-Orphan Drugs: Attaching Value to Treatments for Rare Diseases
- Risk-Sharing Agreements: An Alternative Approach to Pricing Negotiations
- Biosimilars in Europe and the United States
- Theranostics: Insight into a New Medical Model
- Direct-to-Pharmacy Distribution: Managing Relationships in 12 European Markets
- A Survey of the European Hospital Drug Market
- Biosimilars in Europe, an Outlook
- Pharmaceutical Parallel Trade in Europe: A Medium-term Outlook
- European Policies for Medicine: Successfully Developing Pharmaceuticals in 15 European Markets
Drug Prescription and Retailing Behavior
Using specialized marketing tools developed for the health and pharmaceutical industry and leveraging the in-depth expertise of our Paris-based consultants, we provide detailed operational information and analysis of the French and European markets:
- Prescription behavior by disease and area, including hospital, ambulatory, and retirement houses (general practitioners and specialists)
- Drug-delivery behavior (pharmacists, druggists, chemists) by therapeutic class
- Trends in hospital medicine (prescriptions, policies, regulation)
- The provision of healthcare in retirement houses, including policies, regulation, and relationships with insurers
|
|
|
